Geode Capital Management’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$403K Buy
77,054
+30,517
+66% +$91.5K ﹤0.01% 3664
2025
Q4
$67.5K Buy
46,537
+1,303
+3% +$2.55K ﹤0.01% 4181
2025
Q3
$110K Buy
45,234
+17,278
+62% +$40K ﹤0.01% 4104
2025
Q2
$56.5K Sell
27,956
-1,014
-4% -$2.16K ﹤0.01% 4189
2025
Q1
$70.7K Buy
28,970
+9,166
+46% +$19.8K ﹤0.01% 4116
2024
Q4
$33.7K Sell
19,804
-1,005
-5% -$2.8K ﹤0.01% 4306
2024
Q3
$92.6K Buy
20,809
+2,590
+14% +$11.8K ﹤0.01% 4125
2024
Q2
$78.4K Buy
18,219
+3,834
+27% +$17.1K ﹤0.01% 4193
2024
Q1
$59.7K Sell
14,385
-295
-2% -$1.37K ﹤0.01% 4287
2023
Q4
$67.4K Sell
14,680
-4
-0% -$15 ﹤0.01% 4280
2023
Q3
$64.3K Buy
14,684
+2,299
+19% +$13.6K ﹤0.01% 4366
2023
Q2
$69.4K Hold
12,385
﹤0.01% 4440
2023
Q1
$79.1K Hold
12,385
﹤0.01% 4412
2022
Q4
$187K Buy
12,385
+607
+5% +$4.52K ﹤0.01% 4138
2022
Q3
$75K Hold
11,778
﹤0.01% 4676
2022
Q2
$131K Buy
11,778
+311
+3% +$4.58K ﹤0.01% 4474
2022
Q1
$238K Buy
11,467
+431
+4% +$11.9K ﹤0.01% 4291
2021
Q4
$434K Hold
11,036
﹤0.01% 4124
2021
Q3
$570K Buy
11,036
+460
+4% +$17.9K ﹤0.01% 3968
2021
Q2
$390K Buy
10,576
+6,400
+153% +$259K ﹤0.01% 4051
2021
Q1
$157K Buy
+4,176
New +$168K ﹤0.01% 4189

Other funds holding EDSA

Geode Capital Management's EDSA Position: Q1 2026 in Review

Geode Capital Management increased its Edesa Biotech (EDSA) stake by 66% in Q1 2026, buying an estimated $91.5K and bringing the position to 77,054 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Geode Capital Management first reported a position in EDSA in Q1 2021 and has held it in 21 quarters since. The position peaked at $570K in Q3 2021. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

  • Geode Capital Management held 77,054 shares of Edesa Biotech worth $403K as of Q1 2026.
  • Geode Capital Management bought 30,517 Edesa Biotech shares in Q1 2026, an estimated $91.5K.
  • Edesa Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3664 holding.
  • Geode Capital Management first reported a position in Edesa Biotech in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Edesa Biotech position peaked at $570K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.